Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease

Glial cell-line-derived neurotrophic factor (GDNF) is a potent neuroprotective agent in cellular and animal models of Parkinson’s disease (PD). However, CNS delivery of GDNF in clinical trials has proven challenging due to blood-brain barrier (BBB) impermeability, poor diffusion within brain tissue,...

Full description

Bibliographic Details
Main Authors:	Cang Chen, Michael J. Guderyon, Yang Li, Guo Ge, Anindita Bhattacharjee, Cori Ballard, Zhixu He, Eliezer Masliah, Robert A. Clark, Jason C. O’Connor, Senlin Li
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	Molecular Therapy: Methods & Clinical Development
Subjects:	Neurodegenerative diseases Parkinson’s disease Gene therapy Neurotrophic factors GDNF Hematopoietic stem cell
Online Access:	http://www.sciencedirect.com/science/article/pii/S232905011930138X

Similar Items

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits
by: Soledad Marton, et al.
Published: (2019-03-01)

The Future of GDNF in Parkinson's Disease
by: Fredric P. Manfredsson, et al.
Published: (2020-12-01)

The Role of Metals in the Neuroregenerative Action of BDNF, GDNF, NGF and Other Neurotrophic Factors
by: Vincenzo Giuseppe Nicoletti, et al.
Published: (2022-07-01)

How to Build and to Protect the Neuromuscular Junction: The Role of the Glial Cell Line-Derived Neurotrophic Factor
by: Serena Stanga, et al.
Published: (2020-12-01)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
by: Anna-Maija Penttinen, et al.
Published: (2018-06-01)

Biology of GDNF and its receptors — Relevance for disorders of the central nervous system
by: Carlos F. Ibáñez, et al.
Published: (2017-01-01)

Intestinal Epithelial Barrier Maturation by Enteric Glial Cells Is GDNF-Dependent
by: Michael Meir, et al.
Published: (2021-02-01)

The Influence of Neurotrophic Factors BDNF and GDNF Overexpression on the Functional State of Mice and Their Adaptation to Audiogenic Seizures
by: Angelina O. Kustova, et al.
Published: (2022-08-01)

Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson’s Disease with Sleep Disorders
by: Li Wang, et al.
Published: (2023-01-01)

GDNF protects enteric glia from apoptosis: evidence for an autocrine loop
by: Steinkamp Martin, et al.
Published: (2012-01-01)

Lower GDNF Serum Level Is a Possible Risk Factor for Constipation in Patients With Parkinson Disease: A Case–Control Study
by: Gang Chen, et al.
Published: (2022-01-01)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
by: Bin Xiao, et al.
Published: (2022-07-01)

Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF
by: M.E. Emborg, et al.
Published: (2009-11-01)

Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy
by: Tuane Bazanella Sampaio, et al.
Published: (2017-01-01)

3D-printed hyaluronic acid hydrogel scaffolds impregnated with neurotrophic factors (BDNF, GDNF) for post-traumatic brain tissue reconstruction
by: Tatiana A. Mishchenko, et al.
Published: (2022-08-01)

Ultrasound-Triggered Effects of the Microbubbles Coupled to GDNF Plasmid-Loaded PEGylated Liposomes in a Rat Model of Parkinson's Disease
by: Peijian Yue, et al.
Published: (2018-04-01)

Blueberry juice augments exercise-induced neuroprotection in a Parkinson’s disease model through modulation of GDNF levels
by: Sandra L. Castro, et al.
Published: (2022-06-01)

Oxidative stress induced by sustained supraphysiological intrastriatal GDNF delivery is prevented by dose regulation
by: Marcelo Duarte Azevedo, et al.
Published: (2023-12-01)

Effects of transplanted GDNF gene modified marrow stromal cells on focal cerebral ischemia in rat
by: Yunliang eWang, et al.
Published: (2011-12-01)

A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat
by: Yulia A. Sidorova, et al.
Published: (2017-06-01)

Study of GDNF-Family Receptor Alpha 2 And Inhibitory Activity of GDNF-Family Receptor Alpha 2b (GFRα2b) Isoform
by: Yoong, Li Foong, et al.
Published: (2005)

Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
by: Yuling Zhao, et al.
Published: (2022-06-01)

A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies
by: Alicia Arranz-Romera, et al.
Published: (2021-01-01)

A possible role of GDNF expression by which cabergoline use affects corpus callosum
by: Georgios Mitsiakos, et al.
Published: (2018-12-01)

Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain
by: Lars U. Wahlberg, et al.
Published: (2020-04-01)

A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology
by: Serena Stanga, et al.
Published: (2018-05-01)

GDNF Increases Inhibitory Synaptic Drive on Principal Neurons in the Hippocampus via Activation of the Ret Pathway
by: Apostolos Mikroulis, et al.
Published: (2022-10-01)

Possible role of glial cell line-derived neurotrophic factor for predicting cognitive impairment in Parkinson’s disease: a case-control study
by: Ming-Yu Shi, et al.
Published: (2021-01-01)

GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
by: Lois M. Mulligan
Published: (2019-01-01)

MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells
by: Bao-Le Zhang, et al.
Published: (2017-12-01)

Reawakening GDNF's regenerative past in mice and humans
by: Andres Samos, et al.
Published: (2022-06-01)

Opposing Spatially Segregated Function of Endogenous GDNF-RET Signaling in Cocaine Addiction
by: Daniel R. Garton, et al.
Published: (2023-04-01)

Schwann cells migrate along axons in the absence of GDNF signaling
by: Heermann Stephan, et al.
Published: (2012-08-01)

TGF-β1 Increases GDNF Production by Upregulating the Expression of GDNF and Furin in Human Granulosa-Lutein Cells
by: Jingwen Yin, et al.
Published: (2020-01-01)

Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis
by: Wesley M. Stansberry, et al.
Published: (2023-08-01)

Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers
by: Sumonto Mitra, et al.
Published: (2021-08-01)

Endogenous GDNF Is Unable to Halt Dopaminergic Injury Triggered by Microglial Activation
by: Julieta Mendes-Oliveira, et al.
Published: (2023-12-01)

Suicide and Neurotrophin Factors: A Systematic Review of the Correlation between BDNF and GDNF and Self-Killing
by: Stefania De Simone, et al.
Published: (2022-12-01)

Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
by: Karen M. Delgado-Minjares, et al.
Published: (2021-10-01)

Genetic Background Influences Severity of Colonic Aganglionosis and Response to GDNF Enemas in the <i>Holstein</i> Mouse Model of Hirschsprung Disease
by: Rodolphe Soret, et al.
Published: (2021-12-01)